Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Admatop 2.5mg Injection
Manufacturer/Marketed By : ADMAC LIFE SCIENCES
$53.82 $43.06
Admatop 2.5mg Injection is an anti-cancer medicine that contains Topotecan. It is used to treat ovarian and lung cancers that have returned after chemotherapy, and also for advanced cervical cancer...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TOPOTECAN
Active Pharmaceutical Ingredient
Admatop 2.5mg Injection
$53.82
$43.06
Admatop 2.5mg Injection is an anti-cancer medicine that contains Topotecan. It is used to treat ovarian and lung cancers that have returned after chemotherapy, and also for advanced cervical cancer in combination with cisplatin when surgery or radiation is no longer effective. The Admatop dosage is based on body weight and overall health and is given as an injection by a healthcare professional. This medicine is not recommended for children. Patients should avoid grapefruit or grapefruit juice during treatment, as it can increase the absorption of the drug and raise the risk of side effects. One of the common side effects of Admatop injection is neutropenia, a drop in white blood cells that can increase the risk of infection. Admatop neutropenia management irinotecan includes regular blood tests, dose adjustments, or supportive medications like growth factors. Doctors usually manage this through regular blood tests and supportive medication. If you experience fever, unusual bleeding, or signs of infection, inform your doctor right away. Side effects are generally manageable, and many patients respond well to treatment. If you’ve had an allergy to Admatop or its ingredients before, make sure to tell your doctor. The Admatop price may vary depending on location and supplier, so consult a certified oncology pharmacy for accurate cost details.
Active Pharmaceutical Ingredient
Uses
• Ovarian cancer
• Small cell lung cancer
• Advanced cervical cancer
Benefits
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Side Effects
Admatop 2.5 mg injection ovarian cancer side effects include
Most Common Side Effects
• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Anemia
• Hair loss
• Decreased appetite
• Mouth sores
• Fever
• Headache
• Insomnia
• Dizziness
• Muscle weakness
• Back pain
• Difficulty breathing
Common Side Effects
• Bone marrow suppression (increased risk of infection, anemia, and bleeding)
• Gastrointestinal toxicity (diarrhea, vomiting, and dehydration)
• Lung toxicity (difficulty breathing, coughing, and chest pain)
• Neurological toxicity (numbness or tingling in the hands or feet, confusion, and seizures)
• Cardiac toxicity (changes in heart rate and blood pressure)
• Allergic reactions (swelling of the face or throat, difficulty breathing, and hives)
• Liver toxicity (yellowing of the skin or eyes, dark urine, and abdominal pain)
How To Use
Admatop 2.5mg Injection is typically administered by a healthcare provider as an intravenous (IV) infusion in a clinical setting. The dosage and frequency of infusions will vary depending on the patient's individual medical condition, age, weight, and other factors. You should not take a double dose to make up for the second dose.
Safety Advice
• Breast Feeding: It is not clear whether Admatop 2.5mg Injection is excreted in human milk or not. So you should consult a doctor before taking this medication if you are a breastfeeding mother.
• Alcohol: It is recommended to avoid consuming alcohol while taking Admatop 2.5mg Injection, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Admatop 2.5mg Injection is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be a sign of liver damage or inflammation. Patients taking this medication require regular blood tests to monitor liver function.
• Lungs: Admatop 2.5mg Injection is used to treat small-cell lung cancer, which is a type of lung cancer that is often aggressive and difficult to treat. Patients with pre-existing lung conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, should discuss the risks and benefits of treatment with their healthcare provider.
• Driving: Patients receiving Admatop 2.5mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Admatop 2.5mg Injection is unsafe during pregnancy as it can cause fetal harm. It is recommended to avoid this medication during pregnancy.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.